Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
A key supporting study was retracted due to data fabrication, and the related prodrug fosgonimeton saw adverse events in clinical trials
August 9 Product: Lykos Therapeutics Midomafetamine Indication: Post-traumatic stress disorder In one of the years most highly anticipated decisions, the FDA declined to approve Lykos Therapeutics midomafetamine (MDMA)-assisted therapy for post-traumatic stress disorder
Stay well-hydrated and try to eat small, bland meals
Mice engineered to carry the Cys93Ala mutation, which eliminates the thiol group, are unable to generate SNO-Hb and show impaired regulation of blood flow during hypoxia (Sun et al., 2019)
US$ 20.12
US$ 21.82
US$ 20.06
US$ 22.43
US$ 24.98
US$ 23.09
US$ 24.47
US$ 20.38
US$ 25.40
US$ 26.29
US$ 20.61
US$ 23.02
